Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

96.80
Delayed Data
As of 11:33am ET
 -0.88 / -0.90%
Today’s Change
29.46
Today|||52-Week Range
108.00
+64.96%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 102.50, with a high estimate of 123.00 and a low estimate of 82.00. The median estimate represents a +5.89% increase from the last price of 96.80.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Hold stock in Enanta Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.87
Sales
$54.8M
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 42.62%
 
 
 
 
 
 
Growthannually 250.55%
 
 
 
 
 
 

Sales

Growthquarterly 24.51%
 
 
 
 
 
 
Growthannually 96.37%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.